Thermalisation of a two-dimensional photonic gas in a 'white-wall' photon box

Bose-Einstein condensation, the macroscopic accumulation of bosonic particles in the energetic ground state below a critical temperature, has been demonstrated in several physical systems. The perhaps best known example of a bosonic gas, blackbody radiation, however exhibits no Bose-Einstein condensation at low temperatures. Instead of collectively occupying the lowest energy mode, the photons disappear in the cavity walls when the temperature is lowered - corresponding to a vanishing chemical potential. Here we report on evidence for a thermalised two-dimensional photon gas with freely adjustable chemical potential. Our experiment is based on a dye filled optical microresonator, acting as a 'white-wall' box for photons. Thermalisation is achieved in a photon number-conserving way by photon scattering off the dye-molecules, and the cavity mirrors both provide an effective photon mass and a confining potential - key prerequisites for the Bose-Einstein condensation of photons. As a striking example for the unusual system properties, we demonstrate a yet unobserved light concentration effect into the centre of the confining potential, an effect with prospects for increasing the efficiency of diffuse solar light collection.Comment: 15 pages, 3 figure

Bose-Einstein condensation of photons in an optical microcavity

Bose-Einstein condensation, the macroscopic ground state accumulation of particles with integer spin (bosons) at low temperature and high density, has been observed in several physical systems, including cold atomic gases and solid state physics quasiparticles. However, the most omnipresent Bose gas, blackbody radiation (radiation in thermal equilibrium with the cavity walls) does not show this phase transition, because the chemical potential of photons vanishes and, when the temperature is reduced, photons disappear in the cavity walls. Theoretical works have considered photon number conserving thermalization processes, a prerequisite for Bose-Einstein condensation, using Compton scattering with a gas of thermal electrons, or using photon-photon scattering in a nonlinear resonator configuration. In a recent experiment, we have observed number conserving thermalization of a two-dimensional photon gas in a dye-filled optical microcavity, acting as a 'white-wall' box for photons. Here we report on the observation of a Bose-Einstein condensation of photons in a dye-filled optical microcavity. The cavity mirrors provide both a confining potential and a non-vanishing effective photon mass, making the system formally equivalent to a two-dimensional gas of trapped, massive bosons. By multiple scattering off the dye molecules, the photons thermalize to the temperature of the dye solution (room temperature). Upon increasing the photon density we observe the following signatures for a BEC of photons: Bose-Einstein distributed photon energies with a massively populated ground state mode on top of a broad thermal wing, the phase transition occurring both at the expected value and exhibiting the predicted cavity geometry dependence, and the ground state mode emerging even for a spatially displaced pump spot

Strategies to Target Tumor Immunosuppression

The tumor microenvironment is currently in the spotlight of cancer immunology research as a key factor impacting tumor development and progression. While antigen-specific immune responses play a crucial role in tumor rejection, the tumor hampers these immune responses by creating an immunosuppressive microenvironment. Recently, major progress has been achieved in the field of cancer immunotherapy, and several groundbreaking clinical trials demonstrated the potency of such therapeutic interventions in patients. Yet, the responses greatly vary among individuals. This calls for the rational design of more efficacious cancer immunotherapeutic interventions that take into consideration the “immune signature” of the tumor. Multimodality treatment regimens that aim to enhance intratumoral homing and activation of antigen-specific immune effector cells, while simultaneously targeting tumor immunosuppression, are pivotal for potent antitumor immunity

Albumin and multiple sclerosis

A grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.Leakage of the blood–brain barrier (BBB) is a common pathological feature in multiple sclerosis (MS). Following a breach of the BBB, albumin, the most abundant protein in plasma, gains access to CNS tissue where it is exposed to an inflammatory milieu and tissue damage, e.g., demyelination. Once in the CNS, albumin can participate in protective mechanisms. For example, due to its high concentration and molecular properties, albumin becomes a target for oxidation and nitration reactions. Furthermore, albumin binds metals and heme thereby limiting their ability to produce reactive oxygen and reactive nitrogen species. Albumin also has the potential to worsen disease. Similar to pathogenic processes that occur during epilepsy, extravasated albumin could induce the expression of proinflammatory cytokines and affect the ability of astrocytes to maintain potassium homeostasis thereby possibly making neurons more vulnerable to glutamate exicitotoxicity, which is thought to be a pathogenic mechanism in MS. The albumin quotient, albumin in cerebrospinal fluid (CSF)/albumin in serum, is used as a measure of blood-CSF barrier dysfunction in MS, but it may be inaccurate since albumin levels in the CSF can be influenced by multiple factors including: 1) albumin becomes proteolytically cleaved during disease, 2) extravasated albumin is taken up by macrophages, microglia, and astrocytes, and 3) the location of BBB damage affects the entry of extravasated albumin into ventricular CSF. A discussion of the roles that albumin performs during MS is put forth